SynthesisFrontiers in endocrinology2026
Impact of diabetes mellitus on mortality in patients with acute exacerbation of chronic obstructive Pulmonary disease: a meta-analysis and systematic review.
Synthesis in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As one of the most prevalent comorbidities in chronic obstructive pulmonary disease (COPD), diabetes mellitus has drawn growing attention for its potential impact on clinical outcomes in acute exacerbation of COPD (AECOPD). However, the association between diabetes and mortality risk in AECOPD remains controversial. This meta-analysis synthesized available evidence to quantify the effect of diabetes on mortality among AECOPD patients, aiming to provide an evidence-based foundation for clinical risk stratification and individualized intervention. Methods: We systematically searched PubMed, Embase, Cochrane Library, Web of Science, CNKI, and Wanfang databases up to March 2026 for cohort or case-control studies investigating the association between diabetes and mortality in AECOPD patients. Two researchers independently conducted literature screening, data extraction and quality evaluation. The Newcastle-Ottawa Scale (NOS) was used to assess risk of bias. Meta-analysis was performed using Stata 14.0 software. The hazard rations (HR) was used to combine the effect size, and corresponding 95% confidence interval (CI) was computed. Results: A total of 9 studies were included, involving 23,883 participants. In the univariate model, diabetes increased the mortality risk of patients with AECOPD (HR = 1.45, 95%CI (1.19,1.77), P < 0.0001), whereas no significant association was observed in multivariate analysis (HR = 1.50, 95% CI (0.45, 5.00), P = 0.513). Subgroup analysis showed that diabetes increased mortality risk in hospitalized AECOPD patients but not in those admitted to intensive care units. A significant association was found in case-control studies but not in cohort studies, and in studies with a sample size > 1000 but not in smaller studies. Conclusions: This meta-analysis demonstrates inconsistent associations between diabetes and mortality in AECOPD patients, which may be confounded by methodological factors and study design. Current evidence does not support diabetes as an independent risk factor for mortality in AECOPD. Further well-designed, adequately powered prospective cohort studies with rigorous adjustment for confounders are warranted to clarify the true prognostic impact of diabetes on AECOPD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.